Market revenue in 2024 | USD 109.7 million |
Market revenue in 2030 | USD 126.7 million |
Growth rate | 2.4% (CAGR from 2025 to 2030) |
Largest segment | Conventional |
Fastest growing segment | Molecular |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Molecular, Conventional |
Key market players worldwide | BioMerieux SA, Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG ADR, Becton Dickinson & Co, Qiagen NV, Thermo Fisher Scientific Inc, Meridian Bioscience, Hologic, Inc. |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hospital acquired infections diagnostics market will help companies and investors design strategic landscapes.
Conventional was the largest segment with a revenue share of 53.78% in 2024. Horizon Databook has segmented the South Africa hospital acquired infections diagnostics market based on molecular, conventional covering the revenue growth of each sub-segment from 2018 to 2030.
South Africa's HAI diagnostics market is dominated by international companies such as Abbott and bioMérieux, with local firms such as Lancet Laboratories playing a supporting role. The market is characterized by a focus on rapid diagnostic tests for critical infections such as tuberculosis, which often overlaps with hospital-acquired pathogens.
Innovations such as Abbott's point-of-care solutions have gained traction, while local firms emphasize cost-effectiveness and regional distribution networks. Partnerships with public healthcare institutions and nonprofit organizations are key strategies for competitive positioning.
The South African Health Products Regulatory Authority (SAHPRA) governs diagnostic approvals. Regulations align with international standards, facilitating the entry of global players. However, the emphasis on affordable healthcare poses challenges for introducing premium diagnostics.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa hospital acquired infections diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into South Africa hospital acquired infections diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account